We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02662062
Brief Title: Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer (PCR-MIB)

First Submitted : January 13, 2016
First Submitted that Met QC Criteria : January 20, 2016
First Posted : January 25, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 26, 2022
Last Update Posted : May 27, 2022